.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Chinese Patent Office
Baxter
Chubb
Johnson and Johnson
Merck
Boehringer Ingelheim
Cipla
Covington
Federal Trade Commission

Generated: June 26, 2017

DrugPatentWatch Database Preview

PEPCID Drug Profile

« Back to Dashboard

Which patents cover Pepcid, and when can generic versions of Pepcid launch?

Pepcid is a drug marketed by Merck, Salix Pharms, Valeant Pharms North, J And J Consumer Inc, and Merck Sharp Dohme. and is included in nine NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in PEPCID is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and sixty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.

Summary for Tradename: PEPCID

Patents:0
Applicants:5
NDAs:9
Suppliers / Packagers: see list2
Bulk Api Vendors: see list66
Clinical Trials: see list11
Patent Applications: see list5,281
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PEPCID at DailyMed

Pharmacology for Tradename: PEPCID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
PEPCID
famotidine
INJECTABLE;INJECTION019510-001Nov 4, 1986DISCNYesNo► Subscribe► Subscribe
J And J Consumer Inc
PEPCID AC
famotidine
TABLET;ORAL020902-001Aug 5, 1999OTCNoNo► Subscribe► Subscribe
Valeant Pharms North
PEPCID
famotidine
TABLET;ORAL019462-002Oct 15, 1986ABRXYesYes► Subscribe► Subscribe
Merck
PEPCID PRESERVATIVE FREE
famotidine
INJECTABLE;INJECTION019510-004Nov 4, 1986DISCNYesNo► Subscribe► Subscribe
J And J Consumer Inc
PEPCID AC
famotidine
TABLET;ORAL020325-001Apr 28, 1995OTCYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PEPCID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North
PEPCID
famotidine
TABLET;ORAL019462-002Oct 15, 19864,283,408*PED► Subscribe
Merck
PEPCID
famotidine
INJECTABLE;INJECTION019510-001Nov 4, 19864,283,408*PED► Subscribe
Valeant Pharms North
PEPCID
famotidine
TABLET;ORAL019462-001Oct 15, 19864,283,408*PED► Subscribe
Salix Pharms
PEPCID
famotidine
FOR SUSPENSION;ORAL019527-001Feb 2, 19874,283,408*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: PEPCID

Drugname Dosage Strength RLD Submissiondate
calcium carbonate/ famotadine/ magnesium hydroxideChewable Tablets800 mg/ 10 mg/ 165 mg (OTC)Pepcid Complete11/1/2004
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Citi
McKesson
Boehringer Ingelheim
Dow
QuintilesIMS
US Department of Justice
Mallinckrodt
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot